List of Tables
Table 1. Global Non-benzodiazepine Hypnotics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Non-benzodiazepine Hypnotics Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Non-benzodiazepine Hypnotics Market Competitive Situation by Manufacturers in 2024
Table 4. Global Non-benzodiazepine Hypnotics Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Non-benzodiazepine Hypnotics Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Non-benzodiazepine Hypnotics Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Non-benzodiazepine Hypnotics Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Non-benzodiazepine Hypnotics Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Non-benzodiazepine Hypnotics, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Non-benzodiazepine Hypnotics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Non-benzodiazepine Hypnotics, Product Type & Application
Table 12. Global Key Manufacturers of Non-benzodiazepine Hypnotics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Non-benzodiazepine Hypnotics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-benzodiazepine Hypnotics as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Non-benzodiazepine Hypnotics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Non-benzodiazepine Hypnotics Sales by Region (2020-2025) & (K Units)
Table 18. Global Non-benzodiazepine Hypnotics Sales Market Share by Region (2020-2025)
Table 19. Global Non-benzodiazepine Hypnotics Sales by Region (2026-2031) & (K Units)
Table 20. Global Non-benzodiazepine Hypnotics Sales Market Share by Region (2026-2031)
Table 21. Global Non-benzodiazepine Hypnotics Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Non-benzodiazepine Hypnotics Revenue Market Share by Region (2020-2025)
Table 23. Global Non-benzodiazepine Hypnotics Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Non-benzodiazepine Hypnotics Revenue Market Share by Region (2026-2031)
Table 25. North America Non-benzodiazepine Hypnotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Non-benzodiazepine Hypnotics Sales by Country (2020-2025) & (K Units)
Table 27. North America Non-benzodiazepine Hypnotics Sales by Country (2026-2031) & (K Units)
Table 28. North America Non-benzodiazepine Hypnotics Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Non-benzodiazepine Hypnotics Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Non-benzodiazepine Hypnotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Non-benzodiazepine Hypnotics Sales by Country (2020-2025) & (K Units)
Table 32. Europe Non-benzodiazepine Hypnotics Sales by Country (2026-2031) & (K Units)
Table 33. Europe Non-benzodiazepine Hypnotics Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Non-benzodiazepine Hypnotics Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Non-benzodiazepine Hypnotics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Non-benzodiazepine Hypnotics Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Non-benzodiazepine Hypnotics Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Non-benzodiazepine Hypnotics Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Non-benzodiazepine Hypnotics Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Non-benzodiazepine Hypnotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Non-benzodiazepine Hypnotics Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Non-benzodiazepine Hypnotics Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Non-benzodiazepine Hypnotics Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Non-benzodiazepine Hypnotics Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Non-benzodiazepine Hypnotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Non-benzodiazepine Hypnotics Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Non-benzodiazepine Hypnotics Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Non-benzodiazepine Hypnotics Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Non-benzodiazepine Hypnotics Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Non-benzodiazepine Hypnotics Sales (K Units) by Type (2020-2025)
Table 51. Global Non-benzodiazepine Hypnotics Sales (K Units) by Type (2026-2031)
Table 52. Global Non-benzodiazepine Hypnotics Sales Market Share by Type (2020-2025)
Table 53. Global Non-benzodiazepine Hypnotics Sales Market Share by Type (2026-2031)
Table 54. Global Non-benzodiazepine Hypnotics Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Non-benzodiazepine Hypnotics Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Non-benzodiazepine Hypnotics Revenue Market Share by Type (2020-2025)
Table 57. Global Non-benzodiazepine Hypnotics Revenue Market Share by Type (2026-2031)
Table 58. Global Non-benzodiazepine Hypnotics Price (US$/Unit) by Type (2020-2025)
Table 59. Global Non-benzodiazepine Hypnotics Price (US$/Unit) by Type (2026-2031)
Table 60. Global Non-benzodiazepine Hypnotics Sales (K Units) by Application (2020-2025)
Table 61. Global Non-benzodiazepine Hypnotics Sales (K Units) by Application (2026-2031)
Table 62. Global Non-benzodiazepine Hypnotics Sales Market Share by Application (2020-2025)
Table 63. Global Non-benzodiazepine Hypnotics Sales Market Share by Application (2026-2031)
Table 64. Global Non-benzodiazepine Hypnotics Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Non-benzodiazepine Hypnotics Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Non-benzodiazepine Hypnotics Revenue Market Share by Application (2020-2025)
Table 67. Global Non-benzodiazepine Hypnotics Revenue Market Share by Application (2026-2031)
Table 68. Global Non-benzodiazepine Hypnotics Price (US$/Unit) by Application (2020-2025)
Table 69. Global Non-benzodiazepine Hypnotics Price (US$/Unit) by Application (2026-2031)
Table 70. Sanofi-aventis Company Information
Table 71. Sanofi-aventis Description and Business Overview
Table 72. Sanofi-aventis Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Sanofi-aventis Non-benzodiazepine Hypnotics Product
Table 74. Sanofi-aventis Recent Developments/Updates
Table 75. Hikma Pharmaceuticals Company Information
Table 76. Hikma Pharmaceuticals Description and Business Overview
Table 77. Hikma Pharmaceuticals Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Hikma Pharmaceuticals Non-benzodiazepine Hypnotics Product
Table 79. Hikma Pharmaceuticals Recent Developments/Updates
Table 80. Northstar Rx Company Information
Table 81. Northstar Rx Description and Business Overview
Table 82. Northstar Rx Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Northstar Rx Non-benzodiazepine Hypnotics Product
Table 84. Northstar Rx Recent Developments/Updates
Table 85. Teva Pharmaceuticals Company Information
Table 86. Teva Pharmaceuticals Description and Business Overview
Table 87. Teva Pharmaceuticals Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Teva Pharmaceuticals Non-benzodiazepine Hypnotics Product
Table 89. Teva Pharmaceuticals Recent Developments/Updates
Table 90. Torrent Pharma Company Information
Table 91. Torrent Pharma Description and Business Overview
Table 92. Torrent Pharma Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Torrent Pharma Non-benzodiazepine Hypnotics Product
Table 94. Torrent Pharma Recent Developments/Updates
Table 95. Apotex Company Information
Table 96. Apotex Description and Business Overview
Table 97. Apotex Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Apotex Non-benzodiazepine Hypnotics Product
Table 99. Apotex Recent Developments/Updates
Table 100. Endo Company Information
Table 101. Endo Description and Business Overview
Table 102. Endo Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Endo Non-benzodiazepine Hypnotics Product
Table 104. Endo Recent Developments/Updates
Table 105. Mylan Pharmaceuticals Company Information
Table 106. Mylan Pharmaceuticals Description and Business Overview
Table 107. Mylan Pharmaceuticals Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Mylan Pharmaceuticals Non-benzodiazepine Hypnotics Product
Table 109. Mylan Pharmaceuticals Recent Developments/Updates
Table 110. Abbott Company Information
Table 111. Abbott Description and Business Overview
Table 112. Abbott Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Abbott Non-benzodiazepine Hypnotics Product
Table 114. Abbott Recent Developments/Updates
Table 115. Sun Pharmaceutical Company Information
Table 116. Sun Pharmaceutical Description and Business Overview
Table 117. Sun Pharmaceutical Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Sun Pharmaceutical Non-benzodiazepine Hypnotics Product
Table 119. Sun Pharmaceutical Recent Developments/Updates
Table 120. Tapi Teva Company Information
Table 121. Tapi Teva Description and Business Overview
Table 122. Tapi Teva Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Tapi Teva Non-benzodiazepine Hypnotics Product
Table 124. Tapi Teva Recent Developments/Updates
Table 125. Admiron Life Company Information
Table 126. Admiron Life Description and Business Overview
Table 127. Admiron Life Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Admiron Life Non-benzodiazepine Hypnotics Product
Table 129. Admiron Life Recent Developments/Updates
Table 130. Dr. Reddy’s Laboratories Company Information
Table 131. Dr. Reddy’s Laboratories Description and Business Overview
Table 132. Dr. Reddy’s Laboratories Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Dr. Reddy’s Laboratories Non-benzodiazepine Hypnotics Product
Table 134. Dr. Reddy’s Laboratories Recent Developments/Updates
Table 135. Shanghai Pharmaceuticals Company Information
Table 136. Shanghai Pharmaceuticals Description and Business Overview
Table 137. Shanghai Pharmaceuticals Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Shanghai Pharmaceuticals Non-benzodiazepine Hypnotics Product
Table 139. Shanghai Pharmaceuticals Recent Developments/Updates
Table 140. Kanghong Pharmaceutical Company Information
Table 141. Kanghong Pharmaceutical Description and Business Overview
Table 142. Kanghong Pharmaceutical Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Kanghong Pharmaceutical Non-benzodiazepine Hypnotics Product
Table 144. Kanghong Pharmaceutical Recent Developments/Updates
Table 145. Glenmark Life Sciences Company Information
Table 146. Glenmark Life Sciences Description and Business Overview
Table 147. Glenmark Life Sciences Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Glenmark Life Sciences Non-benzodiazepine Hypnotics Product
Table 149. Glenmark Life Sciences Recent Developments/Updates
Table 150. Wockhardt Company Information
Table 151. Wockhardt Description and Business Overview
Table 152. Wockhardt Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Wockhardt Non-benzodiazepine Hypnotics Product
Table 154. Wockhardt Recent Developments/Updates
Table 155. Centaur Pharmaceuticals Company Information
Table 156. Centaur Pharmaceuticals Description and Business Overview
Table 157. Centaur Pharmaceuticals Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Centaur Pharmaceuticals Non-benzodiazepine Hypnotics Product
Table 159. Centaur Pharmaceuticals Recent Developments/Updates
Table 160. Tianjin Tasly Saint Pharmaceuticals Company Information
Table 161. Tianjin Tasly Saint Pharmaceuticals Description and Business Overview
Table 162. Tianjin Tasly Saint Pharmaceuticals Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Tianjin Tasly Saint Pharmaceuticals Non-benzodiazepine Hypnotics Product
Table 164. Tianjin Tasly Saint Pharmaceuticals Recent Developments/Updates
Table 165. Kanghong Pharmaceuticals Company Information
Table 166. Kanghong Pharmaceuticals Description and Business Overview
Table 167. Kanghong Pharmaceuticals Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Kanghong Pharmaceuticals Non-benzodiazepine Hypnotics Product
Table 169. Kanghong Pharmaceuticals Recent Developments/Updates
Table 170. Qilu Pharmaceutical Company Information
Table 171. Qilu Pharmaceutical Description and Business Overview
Table 172. Qilu Pharmaceutical Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 173. Qilu Pharmaceutical Non-benzodiazepine Hypnotics Product
Table 174. Qilu Pharmaceutical Recent Developments/Updates
Table 175. Changzhou Siyao Pharmaceutical Company Information
Table 176. Changzhou Siyao Pharmaceutical Description and Business Overview
Table 177. Changzhou Siyao Pharmaceutical Non-benzodiazepine Hypnotics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 178. Changzhou Siyao Pharmaceutical Non-benzodiazepine Hypnotics Product
Table 179. Changzhou Siyao Pharmaceutical Recent Developments/Updates
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Non-benzodiazepine Hypnotics Distributors List
Table 183. Non-benzodiazepine Hypnotics Customers List
Table 184. Non-benzodiazepine Hypnotics Market Trends
Table 185. Non-benzodiazepine Hypnotics Market Drivers
Table 186. Non-benzodiazepine Hypnotics Market Challenges
Table 187. Non-benzodiazepine Hypnotics Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
Table 191. Authors List of This Report
List of Figures
Figure 1. Product Picture of Non-benzodiazepine Hypnotics
Figure 2. Global Non-benzodiazepine Hypnotics Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Non-benzodiazepine Hypnotics Market Share by Type: 2024 & 2031
Figure 4. Zolpidem Product Picture
Figure 5. Zopiclone Product Picture
Figure 6. Zaleplon Product Picture
Figure 7. Other Product Picture
Figure 8. Global Non-benzodiazepine Hypnotics Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Non-benzodiazepine Hypnotics Market Share by Application: 2024 & 2031
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Other
Figure 13. Global Non-benzodiazepine Hypnotics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Non-benzodiazepine Hypnotics Market Size (2020-2031) & (US$ Million)
Figure 15. Global Non-benzodiazepine Hypnotics Sales (2020-2031) & (K Units)
Figure 16. Global Non-benzodiazepine Hypnotics Average Price (US$/Unit) & (2020-2031)
Figure 17. Non-benzodiazepine Hypnotics Report Years Considered
Figure 18. Non-benzodiazepine Hypnotics Sales Share by Manufacturers in 2024
Figure 19. Global Non-benzodiazepine Hypnotics Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Non-benzodiazepine Hypnotics Players: Market Share by Revenue in Non-benzodiazepine Hypnotics in 2024
Figure 21. Non-benzodiazepine Hypnotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Non-benzodiazepine Hypnotics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Non-benzodiazepine Hypnotics Sales Market Share by Country (2020-2031)
Figure 24. North America Non-benzodiazepine Hypnotics Revenue Market Share by Country (2020-2031)
Figure 25. United States Non-benzodiazepine Hypnotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Non-benzodiazepine Hypnotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Non-benzodiazepine Hypnotics Sales Market Share by Country (2020-2031)
Figure 28. Europe Non-benzodiazepine Hypnotics Revenue Market Share by Country (2020-2031)
Figure 29. Germany Non-benzodiazepine Hypnotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Non-benzodiazepine Hypnotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Non-benzodiazepine Hypnotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Non-benzodiazepine Hypnotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Non-benzodiazepine Hypnotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Non-benzodiazepine Hypnotics Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Non-benzodiazepine Hypnotics Revenue Market Share by Region (2020-2031)
Figure 36. China Non-benzodiazepine Hypnotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Non-benzodiazepine Hypnotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Non-benzodiazepine Hypnotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Non-benzodiazepine Hypnotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Non-benzodiazepine Hypnotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Non-benzodiazepine Hypnotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Non-benzodiazepine Hypnotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Non-benzodiazepine Hypnotics Sales Market Share by Country (2020-2031)
Figure 44. Latin America Non-benzodiazepine Hypnotics Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Non-benzodiazepine Hypnotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Non-benzodiazepine Hypnotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Non-benzodiazepine Hypnotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Colombia Non-benzodiazepine Hypnotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Non-benzodiazepine Hypnotics Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Non-benzodiazepine Hypnotics Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Non-benzodiazepine Hypnotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Non-benzodiazepine Hypnotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Non-benzodiazepine Hypnotics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Non-benzodiazepine Hypnotics by Type (2020-2031)
Figure 55. Global Revenue Market Share of Non-benzodiazepine Hypnotics by Type (2020-2031)
Figure 56. Global Non-benzodiazepine Hypnotics Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Non-benzodiazepine Hypnotics by Application (2020-2031)
Figure 58. Global Revenue Market Share of Non-benzodiazepine Hypnotics by Application (2020-2031)
Figure 59. Global Non-benzodiazepine Hypnotics Price (US$/Unit) by Application (2020-2031)
Figure 60. Non-benzodiazepine Hypnotics Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
